PATENT CLAIM ANALYSIS

Application Number: 15976037
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "249000"]

Abstract:
The present invention relates to novel 6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one derivatives as negative allosteric modulators (NAMs) of the metabotropic glutamate receptor subtype 2 (“mGluR2”). The invention is also directed to pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention or treatment of disorders in which the mGluR2 subtype of metabotropic receptors is involved.

Claim (Index 29):
The method of  claim 25 , wherein the compound is of Formula (I\u2032) wherein R 4  is selected from the group consisting of C 1-4 alkyl, monohalo-C 1-4 alkyl, polyhalo-C 1-4 alkyl, \u2014C 1-4 alkyl-O\u2014C 1-4 alkyl and \u2014C 1-4 alkyl-OH\n or a N-oxide, or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 93.0
- Lexical Diversity: 1.55556
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15976223', '15500319', '15500600', '15500234', '15500205']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8250323469484324
- 35 USC 102 Novelty (BERT): 0.6037486882751408
- Combined Prediction Score: 0.8029039810811033
- Mean Citation Score: 449.709548
- Max Citation Score: 535.078
- Similarity Product: 469.0569160718918

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test